International Consensus on the Evaluation and Management of : Results From a Modified Delphi Survey

• by

• August 14, 2026

FDA approves oral dermatomyositis therapy

Phase 3 findings show improvements in physical function and skin disease activity.

• by Kathryn Wighton

• August 28, 2026

• 2 min

A More Direct Route to Intervention: Baptist Health Expands Surgical Pathways for Drug-Resistant Epilepsy

For patients who continue to have seizures despite appropriate anti-seizure medication therapy, timely referral for surgical evaluation can change the trajectory of care.

• by

• July 17, 2026

• 6 min

Multifactorial Nature of Childhood Stroke Presents a Major Challenge for Diagnosis and Management: A Population-Based Study From Southern Finland

• by Jussi V. Leinonen, Samu Kurki, Siina Pamilo, Juho Immonen, Juha Knuuttila, Matti Hero, Mia Westerholm-Ormio, Pirjo Isohanni, Miika Koskinen

• July 1, 2026